Litcius/Paper detail

MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1

Kun Dong, Qiang Du, Xiao Cui, Peiqi Wan, Christof Kaltenmeier, Jing Luo, Bing Yan, Yihe Yan, David A. Geller

2020Biochemical and Biophysical Research Communications16 citationsDOIOpen Access PDF

Abstract

Hepatocellular carcinoma (HCC) tumors evade death in part by downregulating expression of the tumor suppressor gene Interferon regulatory factor-1 (IRF-1). However, the molecular mechanisms accounting for IRF-1 suppression in HCC have not been well described. In this study, we identified a novel microRNA-301a (miR-301a) binding site in the 3'-untranslated region (3'- UTR) of the human IRF-1 gene and hypothesized a functional role for miR-301a in regulating HCC growth. We show that miR-301a is markedly upregulated in primary HCC tumors and HCC cell lines, while IRF-1 is down-regulated in a post-transcriptional manner. MiR-301a regulates basal and inducible IRF-1 expression in HCC cells with an inverse relationship between miR-301a and IRF-1 expression in HCC cells. Chronic hypoxia induces miR-301a in HCC in vitro and decreases IRF-1 expression. Finally, miR-301a inhibition increases apoptosis and decreases HCC cell proliferation. These findings suggest that targeting of IRF-1 by miR-301a contributes to the molecular basis for IRF-1 downregulation in HCC and provides new insight into the regulation of HCC by miRNAs.

Topics & Concepts

Hepatocellular carcinomamicroRNACancer researchInterferon regulatory factorsInterferonBiologyChemistryCell biologyInternal medicineTranscription factorMedicineGeneImmunologyBiochemistryMicroRNA in disease regulationCancer-related molecular mechanisms researchCircular RNAs in diseases